XML 89 R50.htm IDEA: XBRL DOCUMENT
v3.25.1

Schedule of License Agreements (Details) | 12 Months Ended
--- | ---
Dec. 31, 2024
Elion Oncology Inc [Member] |
Agreement Date | Aug. 23, 2020
Amendment Date | May 17, 2022
Ocuphire Pharma Inc [Member] |
Agreement Date | Jun. 16, 2021
Aposense, Ltd. [Member] |
Agreement Date | May 24, 2020
Yuhan Corporation [Member] |
Agreement Date | Aug. 19, 2020
CoNCERT Pharmaceuticals, Inc [Member] |
Agreement Date | Mar. 19, 2018

X
- Definition License agreements amendment date. + References No definition available. + Details
Name: | PCSA_LicenseAgreementsAmendmentDate
Namespace Prefix: | PCSA_
Data Type: | xbrli:dateItemType
Balance Type: | na
Period Type: | duration

X
- Definition License agreements date. + References No definition available. + Details
Name: | PCSA_LicenseAgreementsDate
Namespace Prefix: | PCSA_
Data Type: | xbrli:dateItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | dei_LegalEntityAxis=PCSA_ElionOncologyIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=PCSA_OcuphirePharmaIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=PCSA_AposenseLtdMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=PCSA_YuhanCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=PCSA_CoNCERTPharmaceuticalsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |